Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Their global presence never compromises on quality
Several clinical trials have demonstrated its effectiveness in promoting significant weight loss in obese patients
Semaglutide is clinically indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as Type 2 diabetes, hypertension, high cholesterol, or cardiovascular disease
The three-way comparison of semaglutide, tirzepatide, and retatrutide provides context for how single-agent retatrutide stacks up
US$ 29.74
US$ 25.85
US$ 28.83
US$ 24.00
US$ 21.51
US$ 26.26
US$ 22.76
US$ 24.28
